A Hungarian researcher holds a petri culture dish in Budapest Monday May 4, 2009. Hungarian pharmaceutical laboratory Omninvest announced that they are ready to develop the A/H1N1 flu vaccine once the sample virus arrives, assuring a production up to 500 000 vaccines per week. Previously Omninvest developed and produced a vaccine against H5N1, Avian flu. [CFP]